Is Immunotech Laboratories Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Immunotech Laboratories Inc (IMMB) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Immunotech Laboratories Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Immunotech Laboratories Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Immunotech Laboratories Inc?

Muslim investors may consider investing in Immunotech Laboratories Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Immunotech Laboratories Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Immunotech Laboratories Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Immunotech Laboratories Inc updated?

The Shariah compliance status of Immunotech Laboratories Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Immunotech Laboratories Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Immunotech Laboratories Inc?

You can check the latest Shariah compliance status of Immunotech Laboratories Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Immunotech Laboratories Inc. Stock Analysis IMMB

United States Health Care Nano Cap

Immunotech Laboratories, Inc. is a drug development company. The company is headquartered in Glendale, California and currently employs 4 full-time employees. The company went IPO on 2002-01-07. The firm is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.

Key Statistics of Immunotech Laboratories Inc (IMMB)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

400.00

P/E Ratio (TTM)

52 Week Range

$0.00$0.00

Market Cap

114.99K

Avg. Volume

54.35K

Dividend Yield

Financial Metrics & Statements of Immunotech Laboratories Inc (IMMB)

FAQ's for Immunotech Laboratories Inc (IMMB)

According to Musaffa’s Shariah screening methodology, Immunotech Laboratories Inc (IMMB) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.